| Literature DB >> 34981681 |
Ji Sung Shim1, Jong Hyun Tae1, Tae Il Noh1, Seok Ho Kang1, Jun Cheon1, Jeong Gu Lee1, Vipul R Patel2, Sung Gu Kang3.
Abstract
BACKGROUND: This study aimed to present the surgical facilitation of neurovascular bundle (NVB) sparing using the toggling technique (30° lens down/up switching) and to evaluate erectile dysfunction (ED) recovery after robot-assisted radical prostatectomy (RARP).Entities:
Keywords: Prostate Cancer; Prostatectomy; Robotics
Mesh:
Year: 2022 PMID: 34981681 PMCID: PMC8723890 DOI: 10.3346/jkms.2022.37.e6
Source DB: PubMed Journal: J Korean Med Sci ISSN: 1011-8934 Impact factor: 2.153
Fig. 1Key surgical steps for retrograde early release using toggling technique. (A) 30° down view: The appropriate dissection approach into the interfascial plane is important in this step. The deeper dissection plane between the prostate fascia and the neurovascular bundle is rarely seen in this view. (B) 30° up view: After the proper dissection of the interfascial plane followed by toggling, the medial side of the neurovascular bundle is visible. The accomplishment of this process guarantees sparing of the whole neurovascular bundle. (C) 30° down view: After toggling again, the final step of the neurovascular bundle sparing process is performed anteriorly. Tunneling, defined as a connection between the anterior aspect of the prostrate and the Denonvillier’s fascia following separation of the neurovascular bundle, can be observed here.
NVB = neurovascular bundle.
Baseline demographics and clinical data of patients with ≥ 1 year follow-up of the two groups
| Parameters | Before matching | After matching | |||||
|---|---|---|---|---|---|---|---|
| With toggling (n = 259) | Without toggling (n = 92) | With toggling (n = 72) | Without toggling (n = 72) | ||||
| Age, yr | 61.4 ± 4.4 | 62.9 ± 3.0 | 0.796 | 62.2 ± 5.7 | 63.8 ± 3.0 | 0.182 | |
| BMI, kg/m2 | 24.2 ± 2.8 | 23.7 ± 4.2 | 0.259 | 24.1 ± 2.8 | 23.9 ± 1.6 | 0.822 | |
| PSA level, ng/mL | 7.9 ± 4.1 | 8.5 ± 2.7 | 0.588 | 7.7 ± 3.6 | 8.8 ± 3.7 | 0.215 | |
| Prostate volume, mL | 32.1 ± 11.3 | 36.0 ± 8.7 | 0.151 | 31.9 ± 12.9 | 37.0 ± 15.0 | 0.138 | |
| Pathologic stage | 0.230 | 0.508 | |||||
| ≤ pT2 | 218 (84) | 73 (79) | 63 (87) | 58 (81) | |||
| ≥ pT3a, pT3b | 41 (16) | 19 (19) | 9 (13) | 14 (19) | |||
| Specimen Gleason score | 0.035 | 0.691 | |||||
| ≤ 6 | 186 (72) | 39 (42) | 50 (64) | 42 (58) | |||
| 7 | 57 (22) | 32 (35) | 21 (27) | 20 (27) | |||
| 8 | 16 (6) | 21 (23) | 7 (9) | 10 (15) | |||
| Positive surgical margin | 0.589 | ||||||
| Overall | 36 (14.0) | 16 (17.3) | 0.294 | 12 (15.6) | 14 (19.4) | ||
| In pT2 cancers | 25/229 (11.0) | 8/73 (13.9) | 9/65 (13.8) | 8/58 (13.8) | |||
| In pT3 cancers | 11/30 (36.7) | 8/19 (42.1) | 3/7 (42.9) | 6/14 (42.8) | |||
| Preoperative SHIM score | 19.3 ± 1.1 | 19.6 ± 2.6 | 0.577 | 19.7 ± 2.1 | 19.3 ± 2.4 | 0.412 | |
| 22–25 | 43 (17) | 19 (21) | 0.254 | 12 (17) | 16 (22) | 0.760 | |
| 17–21 | 216 (83) | 73 (79) | 60 (83) | 56 (78) | |||
Data are shown as mean ± SD or number (%).
BMI = body mass index, PSA = prostate specific antigen, SHIM = Sexual Health Inventory for Men (22–25, no erectile dysfunction; 17–21, mild erectile dysfunction; 12–16, mild-to-moderate erectile dysfunction; 8–11, moderate erectile dysfunction; and 5–7, severe erectile dysfunction).
Neurovascular bundle tunneling success rate between the two groups
| Parameters | With toggling (n = 72) | Without toggling (n = 72) | ||
|---|---|---|---|---|
| NVB tunnelinga success No. | ||||
| None | 3 (2) | 12 (15) | ||
| Unilateral | 16 (22) | 30 (42) | ||
| Bilateral | 53 (76) | 30 (42) | ||
| Overall tunnelinga rate | 87 (125/144) | 74 (106/144) | < 0.001 | |
Values are presented as number (%).
NVB = neurovascular bundle.
aTunneling: creating a space between the anterior prostate and the Denonvillier’s fascia at the mid-prostate level.
Fig. 2Surgeon’s subjective nerve-sparing score on right and left sides in both groups.
Data are shown as mean ± SD.
Fig. 3Kaplan-Meier curve showing erectile dysfunction reduction rate over time. Numbers along the Y-axis represent rate of men at risk (those who were still impotent) at beginning of the corresponding timeline (weeks). Specific percentages depicted in the separate table represent proportion of those men who were potent by the end of the corresponding timeline.
Potency outcomes of representative studies after robot-assisted radical prostatectomy (≥ 1 year follow-up)
| References | No. of patients | Age, yr | Follow-up, mon | Preoperative potency value | NVB sparing approach method | Potency,h % at number months | |||
|---|---|---|---|---|---|---|---|---|---|
| 3 | 6 | 9 | 12 | ||||||
| Zorn et al. | 60 | 60 | 12 | SHIM score ≥ 22 | Bilateral | 47 | 65 | - | 80 |
| Finley et al. | 58 | 57 | 24 | SHIM score ≥ 22 | Bilateral cautery free | 30 | - | 63 | 80 |
| Hakimi et al. | 60 | 60 | 12 | - | Bilateral | 31 | 67 | - | 77 |
| Patel et al. | 1,100 | 56–65 | 18 | SHIM score ≥ 22 | Interfascial bilateral | 67 | 82 | - | 95 |
| Sooriakumaran et al. | 115 | 63 | 24 | -e | Inter + intrafascial | 40 | - | - | 53 |
| Coughlin et al. | 157 | 35–70 | 24 | IIEF average score, 29.78 | Interfascial bilateral | - | 39 | - | 51 |
| Kang et al.g | 150 | 63 | 12 | SHIM score ≥ 17 | With toggling | 48 | 58 | 78 | 82 |
| Without toggling | 27 | 44 | 66 | 75 | |||||
SHIM = Sexual Health Inventory for Men, IIEF = The International Index of Erectile Function Questionnaire, NVB = neurovascular bundle.
aAbility to achieve an erection sufficient for penetration with or without phosphodiesterase-inhibitor medication; bPatient-reported questionnaire (SHIM score, EPIC-26): “erection adequate for penetration?,” “satisfactory?”; cSHIM question 2, 3: achieve and maintain erection satisfactorily for intercourse > half the time; dSHIM question 2, 3: achieve and maintain erection satisfactory for intercourse > half the time, with or without the use of oral phosphodiesterase-5 inhibitors; e“Stiff enough less than half of the time,” “stiff enough more than half of the time,” or “stiff enough every time” in ≥ 1 domains; fMore than half the time or almost always + Less than half the time or about half the time; gSHIM question 2, 3: achieve and maintain erection satisfactorily for intercourse > half the time, with or without the use of oral phosphodiesterase-5 inhibitor; hDefinition of potency in each study.